ICAP Ocean Tomo retained to sell Gentle Waves intellectual property portfolio

Date Announced: 19 Aug 2009

ICAP Ocean Tomo announced today that it has been retained to sell the intellectual property portfolio for the Gentle Waves LED (light emitting diode) Photomodulation® System. This portfolio contains 60 issued and pending patents in the U.S. and worldwide in addition to regulatory approvals, trademarks, logos, and related assets. The technology featured will be of interest to any company competing in the rapidly-growing beauty and cosmeceutical market, estimated to generate over $70 billion in sales in 2009.

Invented by David H. McDaniel, M.D., director of the Institute of Anti-Aging Research and Assistant Professor of Clinical Dermatology and Plastic Surgery at Eastern Virginia Medical School, and developed by Light BioScience, LLC, the Gentle Waves® LED Photomodulation® System has changed the way dermatologists and plastic surgeons approach anti-aging and skin rejuvenation. Scientifically proven to reduce the appearance of fine lines and wrinkles, this application of the technology has become one of the most popular cosmetic treatments offered by doctors and aestheticians worldwide, making the Gentle Waves intellectual property portfolio a highly desirable asset. Its value is strengthened by additional applications of the portfolio in wound healing, stimulation of hair growth, and acne reduction.

The Gentle Waves® system does not rely on thermal energy so there is no trauma to the skin, eliminating pain, discomfort, and side effects. Users spend less than one minute sitting in front of a row of specially designed LED lights pulsating at precise wavelengths and photomodulation codes to stimulate the production of collagen and inhibit the growth of collagenase, an enzyme that breaks down the skin causing it to age prematurely. The Gentle Waves® LED Photomodulation® System is used in conjunction with other procedures such as intense pulsed light and laser treatments, microdermabrasions, chemical peels, and Botox®.

"Over the last 2 years, it (Gentle Waves®) has become the most utilized and indispensable light source in our clinic... patients are noticing enhanced, faster results for skin smoothing with faster resolution of erythema and reduction of irritation from other forms of treatment. We also now use it to reduce bruising and speed wound healing, as well as treat various inflammatory dermatologic conditions,” explains Dr. Robert A Weiss, Associate Professor, Dept of Dermatology, Johns Hopkins University School of Medicine; Director, Maryland Laser, Skin & Vein Institute in Baltimore, Maryland.

In January 2005, the U.S. Food and Drug Administration (FDA) approved Light BioScience, LLC to market and promote the Gentle Waves® LED Photomodulation® technology as a system used to reduce the appearance of periorbital (eye area) wrinkles and rhytids; Gentle Waves® is the first LED device to receive such clearance. On February 25, 2008, the Gentle Waves System became the first LED device to receive a 510(k) over-the-counter (OTC) clearance from the FDA for the treatment of periorbital wrinkles. This clearance paved the way for the Gentle Waves® LED Photomodulation® technology to be directly delivered to the consumer marketplace without a prescription for home use.

“The sale of the intellectual property by ICAP Ocean Tomo is an exciting event, as it will help get this exceptional technology into the hands of millions of ready, willing and able users,” comments Roy G. Geronemus, M.D., Director, Laser & Skin Surgery Center of New York, Clinical Professor of Dermatology, New York University Medical Center, New York, NY.

For more information regarding this portfolio please contact Dean Becker, President, ICAP Ocean Tomo LLC at (561) 309-0011 or Dean.Becker@us.icap.com.

About ICAP Ocean Tomo LLC

ICAP Ocean Tomo is a division of ICAP, the world’s premier voice and electronic interdealer broker. Via Private Patent Brokerage, Live Multi-Lot IP Auctions, and Patent/Bid-Ask™, the first and only brokerage and online marketplace for IP, the team at ICAP Ocean Tomo is uniquely positioned to handle the IP monetization needs of any client. For more information please visit http://www.icapoceantomo.com or call 1-866-779-8363.

About ICAP

ICAP is the world’s premier interdealer broker and provider of post trade services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, foreign exchange, equities and equity derivatives through voice and electronic networks. ICAP has an average daily transaction volume in excess of $2.3 trillion, more than 40% of which is electronic. ICAP is also the source of global market information and research for professionals in the international financial markets. ICAP plc was added to the FTSE 100 Index on 30 June 2006. For more information go to www.icap.com.

Contact
For more information regarding this portfolio please contact Dean Becker, President, ICAP Ocean Tomo LLC at (561) 309-0011 or Dean.Becker@us.icap.com.

E-mail:Dean.Becker@us.icap.com

Web Site:www.icapoceantomo.com

More in Company Newsfeed